Electroporation shows promise for DNA delivery in humans
This article was originally published in Clinica
Executive Summary
A pilot study of Genetronics Biomedical's electroporation-based DNA delivery system, MedPulser, has shown that the device might provide a suitable method of delivering DNA to people suffering from serious or life-threatening diseases, the San Diego, California firm has reported.